NeuBase Therapeutics



NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines that can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.

Sam Backenroth
Chief Financial Officer
William Mann
Chief Operating Officer
Curt Bradshaw
Chief Science Officer
Kia Motesharei
Chief Business & Strategy Officer
Shannon McCarthy
Chief People Officer
Sandra Rojas-Caro
Chief Medical Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.